News
Cardiotoxicity Low for Patients Receiving Paclitaxel, Trastuzumab for ERBB2+ Breast Cancer
Admin • CCON • 11/6/2015
Cardiac toxic effects from paclitaxel with trastuzumab, presenting as grade 3 or 4 left ventricular systolic dysfunction (LVSD) or asymptomatic left ventricular ejection fraction decline (LVEF), were low in patients... Read more »
The Connection Between Cancer Treatment and Cardiac Problems
Admin • CCON • 10/20/2015
When she was just a year old, Brenda Yano was diagnosed with acute leukemia. She was one of the lucky ones, cured by aggressive chemotherapy. Years later, Yano was told... Read more »
Apply Today! Fellowship in “Cardiotoxcity Prevention” – Peter Munk Cardiac Center, Toronto General Hospital, UHN
Admin • CCON • 4/20/2015
The Ted Rogers Program in Cardiotoxicity Prevention at the Peter Munk Center will be offering a formal clinical / research fellowship in advanced heart failure and cardiotoxicity prevention starting July... Read more »
Apply Today! Cardio-Oncology Fellowship Program
Admin • CCON • 2/2/2015
Two Cardio-Oncology Fellowship positions are available for the 2015-2016 academic year at both the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, PA, and at the University of... Read more »
Exercise Prescription During Cancer Treatment
Admin • CCON • 7/17/2014
Amy Kirkham is a PhD Candidate at University of British Columbia specializing in cardiovascular and exercise oncology. Her research involves the use of exercise during and after cancer treatment, including... Read more »